10 May 2022

What a chemist needs to know about patents 2022

Organised by:

SCI's Young Chemists' Panel

London, UK

Register your interest
Synopsis

Intellectual Property (IP) is one of the major outputs of all Research and Development (R&D)
organisations, yet remains an area most scientists are unfamiliar with. SCI’s Young Chemists’ Panel in collaboration with UK-based patent and trademark attorneys and litigators, EIP, will hold this one-day workshop to introduce patent law and IP to those with a scientific background.


Attendees

This event will bring together R&D and legal staff covering a broad spectrum of industries and is particularly relevant to those who wish to learn more about patents and IP in their field. This highly successful event has proved popular with previous attendees and speakers alike, as a chance to gain insight into the world of patents and IP from leading professionals in their field.


Speakers

Dr Darren Smyth

EIP

EIP

Darren Smyth is a UK and European Patent Attorney, and is the head of EIP's chemistry practice group EIP Elements. He is known as an authoritative commentator on IP issues, having been a regular contributor to the IPKat weblog and the Journal of Intellectual Property Law & Practice among others.
Darren's clients range from multinational chemical and pharmaceutical companies to universities, spin-outs and start-ups. For these clients, in addition to patent drafting and prosecution, Darren regularly advises on portfolio management issues, handling of the invention disclosure process, validity and freedom to operate opinions, acquisition of IP, and purchaser and vendor due diligence. He is also experienced in contentious work, including oppositions and appeals at the European patent office, and litigation in the UK and other European jurisdictions.
Darren is on the committee of IP Out, the LGBT+ networking group within the IP Inclusive initiative in the UK Intellectual Property professions, and was a speaker at its inaugural event.

Jared Barnard

EIP

EIP

Jared works for EIP US LLP as a Registered Patent Attorney and is based in Denver, Colorado. With a background in molecular biology, Jared specializes in preparing and prosecuting patent applications and counseling clients on biotech, pharmaceutical, medical device, and mechanical related inventions. Jared has worked for a variety of law firms including international law firms and served as in-house counsel to private companies. His experience includes advising clients regarding numerous IP issues including in-licensing and out-licensing of technologies and managing the worldwide patent portfolios for life sciences and biotechnology companies. He particularly enjoys counseling and advising clients on IP and patent issues related to mergers and acquisitions.

Dr Jen Le Mière

Kymab Ltd (a Sanofi Company)

Jen works for Kymab Ltd (a Sanofi Company), a biotech start-up based in Cambridge, which was acquired by Sanofi in April 2021. Kymab is focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary antibody platform. Kyamb’s portfolio includes antibody development in the areas of immuno-oncology, inflammation, haematology and infectious disease. Jen has extensive experience of managing collaborations with academics and biotech companies and advising on all aspects of licencing, freedom-to-operate and due diligence. She enjoys the contentious side of patent work, having conducted numerous Oral Proceedings before the EPO, and been involved in Irish and German litigation as well as depositions for US litigation. Of note, Jen was a key member of the litigation team in Regeneron v Kymab, from UK first instance through to the UK Supreme Court which handed down its decision in Kymab’s favour in June 2020. Previously, Jen worked at GSK, in medicinal chemistry, inhaled medicines and the antibody technology group.

Dr Robert Lundie Smith

EIP

EIP

Robert Lundie Smith is a partner in EIP, focusing on highly complex patent litigation. Robert has an Msci in chemistry and a PhD in Chemical Physics, both from King’s College London. Prior to turning to the law, Robert worked for two years as a post doc at the University of Lund in Sweden focusing on ultrafast laser and x-ray based studies of structural changes and electron dynamics in organometallics and associated solar cells.


Programme

Tuesday 10 May

9:00
Registration and refreshments
9:30
What is a patent? Dr Darren Smyth
What is a patent, how do you get one, who owns it, how long does it take, how long does it last, what rights does it give you and what does it all mean?
10:00
Inventorship and ownership of patents, Jared Barnard
Who should be included as an inventor of a patent? Issues relating to ownership of patents and the importance of inventorship and experimental records.
10:30
Patentability before the patent office, Dr Darren Smyth
What is a patentable chemical invention? What are the requirements for patentability
11:00
Refreshment break
11:30
Patentability when you are in court, Dr Robert Lundie Smith
Litigation case studies of patent validity.
12:00
Patent filing strategies; a pharmaceutical industry perspective, Dr Jen Le Mière
Relative strengths of patents; strategies to cover your product's unique selling point; how to decide which countries to seek protection; building a patent portfolio for optimum effect.
13:00
Lunch
14:00
Patent specifications and chemical claims, Dr Darren Smyth
How to read and interpret a patent specification. Patents as a source of information. Varieties of patent claims used in a chemical context. Timing of patent filings for optimising protection and value.
14:40
Infringement and enforcement, Dr Robert Lundie Smith
How to proceed when your patent is infringed - or you are accused of infringing. What constitutes patent infringement? Strategies to avoid infringement. Unitary Patent.
15:20
Refreshment break
15:50
US patent litigation, Jared Barnard
What happens when a patent is litigated in the US and how you can prepare now for when your patents are litigated. Discussion of the duty to disclose relevant information to the U.S. Patent and Trademark Office when obtaining a U.S. patent.
16:30
Patent litigation from an in-house perspective, Dr Jen Le Mière
Before litigation: monitoring for infringement/infringers; how your (written) past may come back to haunt you & discovery; dealing with experts; managing multi-country litigation.
17:10
Panel Session
17:30
Networking Reception

Venue and Contact

SCI

14/15 Belgrave Square
London
SW1X 8PS

Conference Team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org


Become an SCI Member and save on this and future events

See Membership Options

Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations


Booking Process/Deadlines

Booking terms and conditions


CPD Information


Sponsors

Organising Committee
  • Silvia Bonomo, AstraZeneca
  • Fiona Laraman, AstraZeneca

Exhibition and Sponsorship

An exhibition will take place alongside the conference during refreshment breaks for companies and related organisations who may wish to exhibit. For further information and prices, please email conferences@soci.org. Spaces are limited and will be allocated on a first come, first served basis.